
AstraZeneca
- Home
- Companies
- AstraZeneca
- Products
- Model ZD1402 - Phase II - Asthma
Model ZD1402 - Phase II - Asthma
FromAstraZeneca
Mechanism: Inhaled IL-4Ra. Area under investigation: asthma. Date commenced phase: Q2 2021. Estimated Filing Acceptance: Country US: EU: Japan:China: Additional information: Partnered product. Status change: